These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
95 related items for PubMed ID: 16309373
21. [Changes in blood concentrations of bone-specific biomarkers, osteocalcin and C-telopeptide, in third or higher parity sows after administration of calcium and vitamin D]. Counotte GH, Groenland G, Salden N. Tijdschr Diergeneeskd; 2009 Mar 15; 134(6):230-7. PubMed ID: 19353919 [Abstract] [Full Text] [Related]
22. The effect of gonadotropin-releasing hormone agonist on type I collagen C-telopeptide and N-telopeptide: the predictive value of biochemical markers of bone turnover. Amama EA, Taga M, Minaguchi H. J Clin Endocrinol Metab; 1998 Feb 15; 83(2):333-8. PubMed ID: 9467536 [Abstract] [Full Text] [Related]
23. The phytoestrogen genistein reduces bone loss in short-term ovariectomized rats. Fanti P, Monier-Faugere MC, Geng Z, Schmidt J, Morris PE, Cohen D, Malluche HH. Osteoporos Int; 1998 Feb 15; 8(3):274-81. PubMed ID: 9797913 [Abstract] [Full Text] [Related]
26. Effect of zoledronic acid on markers of bone turnover and mineral density in osteoporotic patients with beta-thalassaemia. Perifanis V, Vyzantiadis T, Tziomalos K, Vakalopoulou S, Garipidou V, Athanassiou-Metaxa M, Harsoulis F. Ann Hematol; 2007 Jan 15; 86(1):23-30. PubMed ID: 17013645 [Abstract] [Full Text] [Related]
28. The effects of Cosmos caudatus (Ulam Raja) supplementation on bone biochemical parameters in ovariectomized rats. Mohamed N, Yin CM, Shuid AN, Muhammad N, Babji AS, Soelaiman IN. Pak J Pharm Sci; 2013 Sep 15; 26(5):1027-31. PubMed ID: 24035963 [Abstract] [Full Text] [Related]
29. The bone regenerative effects of fucosterol in in vitro and in vivo models of postmenopausal osteoporosis. Lee DG, Park SY, Chung WS, Park JH, Shin HS, Hwang E, Kim IH, Yi TH. Mol Nutr Food Res; 2014 Jun 15; 58(6):1249-57. PubMed ID: 24604889 [Abstract] [Full Text] [Related]
31. Serum N-terminal telopeptide of type I collagen as a biomarker for predicting bone density loss in patients with Crohn disease. Ishida N, Higuchi T, Miyazu T, Tamura S, Suzuki S, Tani S, Yamade M, Iwaizumi M, Hamaya Y, Osawa S, Furuta T, Sugimoto K. PLoS One; 2021 Jun 15; 16(4):e0250658. PubMed ID: 33905438 [Abstract] [Full Text] [Related]
32. Role of type I collagen C telopeptide, bone-specific alkaline phosphatase and osteocalcin in the assessment of bone status in postmenopausal women. Trento LK, Pietropolli A, Ticconi C, Gravotta E, De Martino MU, Fabbri A, Piccione E. J Obstet Gynaecol Res; 2009 Feb 15; 35(1):152-9. PubMed ID: 19215563 [Abstract] [Full Text] [Related]
33. Prevention of glucocorticoid induced osteoporosis with alendronate or alfacalcidol: relations of change in bone mineral density, bone markers, and calcium homeostasis. Jacobs JW, de Nijs RN, Lems WF, Geusens PP, Laan RF, Huisman AM, Algra A, Buskens E, Hofbauer LC, Oostveen AC, Bruyn GA, Dijkmans BA, Bijlsma JW. J Rheumatol; 2007 May 15; 34(5):1051-7. PubMed ID: 17407214 [Abstract] [Full Text] [Related]
39. The amino-terminal propeptide (PINP) of type I collagen is a clinically valid indicator of bone turnover and extent of metastatic spread in osseous metastatic breast cancer. Pollmann D, Siepmann S, Geppert R, Wernecke KD, Possinger K, Lüftner D. Anticancer Res; 2007 Oct 15; 27(4A):1853-62. PubMed ID: 17649784 [Abstract] [Full Text] [Related]
40. Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease. Bjøro K, Brandsaeter B, Wiencke K, Bjøro T, Godang K, Bollerslev J, Schrumpf E. Scand J Gastroenterol; 2003 Mar 15; 38(3):320-7. PubMed ID: 12737449 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]